PNC Financial Services Group
AST.WS

PNC Financial Services Group’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

PNC Financial Services Group’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8
Closed – – 4401
2017
Q2 		$0 Hold
8
– – ﹤0.01% 4357
2017
Q1 		$0 Hold
8
– – ﹤0.01% 4353
2016
Q4 		$0 Hold
8
– – ﹤0.01% 4252
2016
Q3 		$0 Hold
8
– – ﹤0.01% 4688
2016
Q2 		$0 Buy
+8
New +$4 ﹤0.01% 4728

PNC Financial Services Group's AST.WS Position: Q3 2017 in Review

PNC Financial Services Group sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 8 shares.

PNC Financial Services Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • PNC Financial Services Group reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 8 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • PNC Financial Services Group first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • PNC Financial Services Group's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on PNC Financial Services Group's 13F filing for Q3 2017, filed 13 Nov 2017.